The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Petition for Rulemaking of Andrew Gonzalez
NewsGuard/World Federation of Advertising
Facebook, Inc., FTC v. (FTC v. Meta Platforms, Inc.)
The Federal Trade Commission has sued Facebook, alleging that the company is illegally maintaining its personal social networking monopoly through a years-long course of anticompetitive conduct. The complaint alleges that Facebook has engaged in a systematic strategy—including its 2012 acquisition of up-and-coming rival Instagram, its 2014 acquisition of the mobile messaging app WhatsApp, and the imposition of anticompetitive conditions on software developers—to eliminate threats to its monopoly. The Commission vote to authorize staff to file for a permanent injunction and other equitable relief in the U.S. District Court for the District of Columbia was 3-2. Commissioners Noah Joshua Phillips and Christine S. Wilson voted no.
20251614: Illumina, Inc.; Standard BioTools, Inc.
20260566: Green Dot Acquisition Partners, LP; Green Dot Corporation
20260573: David Lazovsky; Marvell Technology, Inc.
20260574: Marvell Technology, Inc.; Celestial AI, Inc.
20260576: Round Hill Music Encore Fund LP; Round Hill Music Royalty Fund II LP
20260584: ArcLight Energy Partners Fund VII, L.P.; IIF US Holding 2 LP
20260655: PrimeFlight Investments, LP; Atlantic Street Capital III, LP
20260645: Herschend Family Entertainment Corporation; Gary Norton
Golden Sunrise Nutraceutical, Inc.
In July 2020, the Federal Trade Commission filed a complaint in federal court against the California-based marketers and promoters of bogus treatments for serious medical conditions. The defendants are two corporations headquartered in Porterville, California, and two of their executives: Huu Tieu, president and CEO of both companies; and Stephen Meis, Medical Director and board member of Golden Sunrise Nutraceutical. The complaint alleged that defendants have promoted and sold a variety of products through "plans of care" ranging in price from $23,000 to $200,000, which falsely claim to treat or cure COVID-19, cancer, Parkinson's disease, etc. On June 14, 2021, the FTC announced a proposed order barring the defendants from making bogus health claims. In January 2024, the FTC announced the process defrauded consumers can use to seek refunds. In February 2026, the FTC announced it was sending refund checks to eligible consumers, as well as an online process for eligible consumers who have not yet submitted a claim to do so.
Revised Jurisdictional Thresholds for Section 8 of the Clayton Act
Dun & Bradstreet, Inc., d/b/a D&B
To settle Federal Trade Commission charges that it engaged in deceptive and unfair practices, Dun & Bradstreet (D&B) has agreed to an order requiring substantial changes in the firm’s operations that will benefit small- and mid-sized businesses. Under the proposed order, D&B will also provide refunds to certain businesses that purchased the company’s products in the belief that using the products would improve their business credit scores and ratings.